The rising popularity in GLP-1 agonists for diabetes has generated a debate about delivery routes : transdermal systems versus pills . Usually , GLP-1 therapies were exclusively available in tablet form, https://vinnyynqf711393.qowap.com/99984128/glp-1-transdermal-delivery-systems-vs-pills-which-suitable-for-the-patient